Literature DB >> 1356786

Regulation of interleukin-4 production in human mononuclear cells.

W Holter1, O Majdic, F S Kalthoff, W Knapp.   

Abstract

Interleukin (IL)-4 is a cytokine with a broad range of effects on immune cells, however, little is known regarding the regulation of its production in freshly isolated human peripheral blood mononuclear cells (PBMC). Here we report the production of IL-4 in such cells following stimulation with monoclonal antibodies (mAb) directed against different cell surface antigens. We show that triggering via CD2 is more efficient for IL-4 production than triggering via the CD3 complex. The addition of a CD28 mAb enhances IL-4 production approximately threefold. Cell depletion experiments show that among CD2 plus CD28-stimulated PBMC the production of IL-4 is restricted to the CD8-CD45RA-T cell subpopulation. mAb interfering with the binding of IL-2 to its receptor can inhibit the production of IL-4 in CD2 plus CD28-stimulated PBMC. As IL-2 induces cell proliferation and production of interferon-gamma, but not production of IL-4, it follows that IL-2 is necessary but not sufficient for IL-4 production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356786     DOI: 10.1002/eji.1830221047

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.

Authors:  B Grubeck-Loebenstein; K Trieb; A Sztankay; W Holter; H Anderl; G Wick
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

2.  The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells.

Authors:  J Wang; T Yan; B Simmer; F Emmrich
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

3.  Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors.

Authors:  D M Bullens; A Kasran; X Peng; K Lorré; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

4.  Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

Authors:  G A Arreaza; M J Cameron; A Jaramillo; B M Gill; D Hardy; K B Laupland; M J Rapoport; P Zucker; S Chakrabarti; S W Chensue; H Y Qin; B Singh; T L Delovitch
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines.

Authors:  K Rafiq; D M Bullens; A Kasran; K Lorré; J L Ceuppens; S W Van Gool
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

6.  IgE production in atopic patients is not related to IL-4 production.

Authors:  C T van der Pouw Kraan; R C Aalberse; L A Aarden
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  Influence of CD28 co-stimulation on cytokine production is mainly regulated via interleukin-2.

Authors:  H M Kuiper; R de Jong; M Brouwer; K Lammers; J Wijdenes; R A van Lier
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

8.  CDw60: a marker for human CD8+ T helper cells.

Authors:  E P Rieber; G Rank
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.